Stock Research for APNHF


Featured Broker: Ally Invest

Get the due diligence for another stock.


APNHF Stock Chart & Research Data

The APNHF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APNHF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


APNHF Due diligence Resources & Stock Charts

The APNHF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APNHF Detailed Price Forecast - CNN Money CNN View APNHF Detailed Summary - Google Finance
Yahoo View APNHF Detailed Summary - Yahoo! Finance Zacks View APNHF Stock Research & Analysis -

Stock Analysis

TradeIdeas View APNHF Trends & Analysis - Trade-Ideas Barrons View APNHF Major Holders - Barrons
NASDAQ View APNHF Call Transcripts - NASDAQ Seeking View APNHF Breaking News & Analysis - Seeking Alpha
Spotlight View APNHF Annual Report - OTC Report View APNHF OTC Short Report -
TradeKing View APNHF Fundamentals - TradeKing Charts View APNHF SEC Filings - Bar Chart
WSJ View Historical Prices for APNHF - The WSJ Morningstar View Performance/Total Return for APNHF - Morningstar
MarketWatch View the Analyst Estimates for APNHF - MarketWatch CNBC View the Earnings History for APNHF - CNBC
StockMarketWatch View the APNHF Earnings - StockMarketWatch MacroAxis View APNHF Buy or Sell Recommendations - MacroAxis
Bullish View the APNHF Bullish Patterns - American Bulls Short Pains View APNHF Short Pain Metrics -

Social Media Mentions

StockTwits View APNHF Stock Mentions - StockTwits PennyStocks View APNHF Stock Mentions - PennyStockTweets
Twitter View APNHF Stock Mentions - Twitter Invest Hub View APNHF Investment Forum News - Investor Hub
Yahoo View APNHF Stock Mentions - Yahoo! Message Board Seeking Alpha View APNHF Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for APNHF - Insider Cow View Insider Transactions for APNHF - Insider Cow
CNBC View APNHF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APNHF - OTC Markets
Yahoo View Insider Transactions for APNHF - Yahoo! Finance NASDAQ View Institutional Holdings for APNHF - NASDAQ

Stock Charts

FinViz View APNHF Stock Insight & Charts - StockCharts View APNHF Investment Charts -
BarChart View APNHF Stock Overview & Charts - BarChart Trading View View APNHF User Generated Charts - Trading View

Latest Financial News for APNHF

South African drugmaker Aspen secures 3.4 billion euro credit line
Posted on Thursday May 17, 2018

Aspen Pharmacare, Africa's biggest generic drugmaker, said on Thursday it had secured a 3.4 billion euro ($4 billion) credit facility for refinancing debt at three of its subsidiaries. Aspen, which has operations in 50 countries, said the facilities were 70 percent oversubscribed and would be used for Aspen Finance, Pharmacare Limited t/a Aspen Pharmacare and Aspen Asia Pacific.

Aspen Moves Production to New $79 Million South Africa Plant
Posted on Monday May 07, 2018

Aspen Pharmacare Holdings Ltd. is relocating the production of drugs for late-stage cancer, Parkinson’s disease and some auto-immune illnesses to South Africa from regions including Europe. The move will help secure supply as manufacturing of the pharmaceuticals is currently outsourced to other companies, Chief Executive Officer Stephen Saad told reporters Monday in Port Elizabeth, where the 1 billion rand ($80 million) unit has been built. Aspen is Africa’s biggest drugmaker with operations in more than 150 countries and is valued at about 121 billion rand.

Aspen expands revenue-boosting therapeutic unit with new $80 million plant
Posted on Monday May 07, 2018

South African drug maker Aspen Pharmacare will produce up to 3.6 billion pills a year at its new manufacturing plant as it expands its therapeutic portfolio, Chief Executive Stephen Saad said on Monday at the official launch. Aspen, with operations in 50 countries, has restructured its business to focus on therapeutic products such as steroids, oncolytic and hormonal replacement therapy products, which helped to lift its first-half earnings.

Aspen Pares Declines as Viceroy Said to Have No Report Imminent
Posted on Tuesday March 13, 2018

Aspen Pharmacare Holdings Ltd. pared the biggest decline in two months in Johannesburg trading as speculation eased that the South African drugmaker is about to be the subject of a report by short-seller ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.